1M
EVH icon

13D Management’s Evolent Health EVH Stock Holding History

13D Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-287,703
Closed -$8.84M – 32
2022
Q2 		$8.84M Buy
287,703
+17,878
+7% +$521K 3.91% 8
2022
Q1 		$8.71M Sell
269,825
-209,403
-44% -$5.48M 3.32% 11
2021
Q4 		$13.3M Sell
479,228
-33,272
-6% -$954K 5.08% 4
2021
Q3 		$15.9M Hold
512,500
– – 5.91% 1
2021
Q2 		$10.8M Sell
512,500
-6,800
-1% -$136K 3.72% 11
2021
Q1 		$10.5M Buy
519,300
+34,800
+7% +$662K 3.89% 8
2020
Q4 		$7.77M Sell
484,500
-138,700
-22% -$1.83M 3.21% 16
2020
Q3 		$7.73M Buy
+623,200
New +$7.33M 3.41% 16

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

13D Management's EVH Position: Q3 2022 in Review

13D Management sold out of Evolent Health (EVH) in Q3 2022, closing a stake of 287,703 shares — an estimated $8.84M sold.

13D Management first reported a position in EVH in Q3 2020 and held it in 8 quarters. The position peaked at $15.9M in Q3 2021. 251 funds tracked by Wall St. Rank hold EVH as of Q3 2022.

  • 13D Management reported no remaining Evolent Health position as of Q3 2022 after selling out during the quarter.
  • 13D Management sold 287,703 Evolent Health shares in Q3 2022, an estimated $8.84M.
  • 13D Management first reported a position in Evolent Health in Q3 2020 and held it in 8 quarters.
  • 13D Management's Evolent Health position peaked at $15.9M in Q3 2021.
  • 251 funds tracked by Wall St. Rank held Evolent Health as of Q3 2022.

Based on 13D Management's 13F filing for Q3 2022, filed 14 Nov 2022.